Concourse Financial Group Securities’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $124K | Sell |
|
|||||
|
2024
Q3 | $192K | Sell |
|
|||||
|
2024
Q2 | $208K | Buy |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $203K | Sell |
|
|||||
|
2023
Q3 | $187K | Sell |
|
|||||
|
2023
Q2 | $212K | Buy |
|
|||||
|
2023
Q1 | $179K | Buy |
|
|||||
|
2022
Q4 | $191K | Sell |
|
|||||
|
2022
Q3 | $189K | Sell |
|
|||||
|
2022
Q2 | $658K | Sell |
|
|||||
|
2022
Q1 | $917K | Sell |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $1.21M | Buy |
|
|||||
|
2021
Q2 | $1.01M | Buy |
|
|||||
|
2021
Q1 | $712K | Sell |
|
|||||
|
2020
Q4 | $617K | Buy |
|
|||||
|
2020
Q3 | $480K | Buy |
|
|||||
|
2020
Q2 | $300K | Buy |
|
|||||
|
2020
Q1 | $217K | Buy |
|
|||||
|
2019
Q4 | $229K | Buy |
|
|||||
|
2019
Q3 | $8K | Sell |
|
|||||
|
2019
Q2 | $25K | Buy |
|
|||||
|
2019
Q1 | $7K | Sell |
|
|||||
|
2018
Q4 | $6K | Sell |
|
|||||
|
2018
Q3 | $9K | Buy |
|